New 2023 Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Br J Haematol.
New 2023 Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Alicia Rovó Journal Am J Hematol.
New 2023 Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author V Potter Journal Bone Marrow Transplant.
2023 Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Carmelo Gurnari Journal Lancet Haematol.
2023 Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Juan Carlos Hernández-Boluda Journal Bone Marrow Transplant.
2023 Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Rémi Tilmont Journal Bone Marrow Transplant.
2023 Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial Group Chronic Malignancies Working Party (CMWP) 1st listed author Thomas Schroeder Journal Haematologica.
2023 A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis Group Chronic Malignancies Working Party (CMWP) 1st listed author Roni Tamari Journal Blood Adv.
2023 Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Bone Marrow Transplant.
2023 Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study Group Chronic Malignancies Working Party (CMWP) 1st listed author Nico Gagelmann Journal Eur J Haematol.
2023 The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Olivier Tournilhac Journal Bone Marrow Transplant.
2023 Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Hemasphere.